Filing Details

Accession Number:
0001181431-13-006517
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-04 19:09:34
Reporting Period:
2013-01-31
Filing Date:
2013-02-04
Accepted Time:
2013-02-04 19:09:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293310 Kalobios Pharmaceuticals Inc KBIO Pharmaceutical Preparations (2834) 770557236
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1108554 Sofinnova Venture Partners V Lp C/o Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1130859 Sofinnova Venture Affiliates V Lp C/o Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1133066 Sofinnova Venture Principals V Lp C/o Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1245624 James Healy C/o Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
Yes No Yes No
1294339 Sofinnova Management V Llc C/o Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
1362315 Sofinnova Management V 2005, Llc C/o Sofinnova Ventures
2800 Sand Hill Road, Suite 150
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-31 2,923 $8.00 3,173 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-01-31 366,592 $8.00 374,205 No 4 P Indirect See footnote
Common Stock Acquisiton 2013-01-31 5,485 $8.00 5,601 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. Reflects 1-for-3.56147 reverse stock split which became effective on January 15, 2013.
  2. Shares are held directly by Sofinnova Venture Affiliates V, L.P. ("SV V Affiliates"). Sofinnova Management V, L.L.C. ("SV V LLC"), the general partner of SV V Affiliates, and James I. Healy, a director of the Issuer, Michael F. Powell, and Alain L. Azan, the managing members of SV V LLC, may be deemed to share voting and dispositive power over the shares held by SV V Affiliates. Such persons and entities disclaim beneficial ownership of shares held by SV V Affiliates except to the extent of any pecuniary interest therein.
  3. Shares are held directly by Sofinnova Venture Partners V, L.P. ("SV V Partners"). SV V LLC and Sofinnova Management V 2005, L.L.C. ("SV V 2005 LLC"), the general partners of SV V Partners, and James I. Healy, a director of the Issuer, Michael F. Powell, and Alain L. Azan, the managing members of SV V LLC and SV V 2005 LLC, may be deemed to share voting and dispositive power over the shares held by SV V Partners. Such persons and entities disclaim beneficial ownership of shares held by SV V Partners except to the extent of any pecuniary interest therein.
  4. Shares are held directly by Sofinnova Venture Principals V, L.P. ("SV V Principals"). SV V LLC, the general partner of SV V Principals, and James I. Healy, a director of the Issuer, Michael F. Powell, and Alain L. Azan, the managing members of SV V LLC, may be deemed to have shared voting and dispositive power over the shares owned by SV V Principals. Such persons and entities disclaim beneficial ownership over the shares owned by SV V Principals except to the extent of any pecuniary interest therein.